XTB S.A. (LON:0RGR)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	748.2	857.03	791.17	766.1	237.83	402.09
Depreciation & Amortization, Total	20.58	19.55	16.84	11.76	8.68	7.53
Change in Accounts Payable	1,838	1,527	310.39	317.24	807.25	629.45
Change in Other Net Operating Assets	-1,697	-1,442	-313.04	-142.01	-778.53	-531.62
Other Operating Activities	-5.25	-12.43	-279.99	341.73	-4.85	22.2
Operating Cash Flow	672.89	828.26	479.25	1,149	199.01	469.14
Capital Expenditures	-19.34	-19.28	-14.46	-12.63	-7.81	-4.35
Sale (Purchase) of Intangibles	-0.27	-1.38	-0.11	-1.12	-0.21	-0.32
Investment in Securities	368.41	-24.61	-30.1	-24.78	60.51	-382.02
Other Investing Activities	21.96	22.37	325.54	-290.19	2.38	2.47
Investing Cash Flow	370.78	-22.88	280.87	-328.7	54.89	-384.23
Long-Term Debt Repaid	-	-10.55	-11.4	-5.02	-5.74	-4.37
Net Debt Issued (Repaid)	-10.4	-10.55	-11.4	-5.02	-5.74	-4.37
Issuance of Common Stock	7.29	7.26	14.54	-	-	-
Repurchase of Common Stock	-7.75	-7.75	-	-	-	-
Common Dividends Paid	-590.2	-590.2	-570.48	-176.08	-210.12	-28.17
Other Financing Activities	-0.99	-0.77	-1.11	-0.84	-0.31	-0.31
Financing Cash Flow	-602.05	-602.01	-568.46	-181.93	-216.17	-32.85
Foreign Exchange Rate Adjustments	-4.21	6.25	-4.27	-5.36	9.46	5.79
Net Cash Flow	437.41	209.62	187.4	633.11	47.19	57.85
Free Cash Flow	653.55	808.98	464.79	1,136	191.2	464.78
Free Cash Flow Growth	0.63%	74.05%	-59.10%	494.38%	-58.86%	709.89%
Free Cash Flow Margin	34.72%	43.54%	28.95%	78.44%	30.56%	58.18%
Free Cash Flow Per Share	5.56	6.88	3.95	9.68	1.63	3.96
Cash Interest Paid	1.15	1.05	2.67	0.84	0.31	0.31
Cash Income Tax Paid	175.11	201.62	146.03	133.73	47.97	92.19

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.